Protagonist Therapeutics PTGX
NASDAQ PTGX
$145.65 -3.15 (-2.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Protagonist Therapeutics (PTGX) Net Shares Issued and Repurchased (2015 - 2025)

Analysis

Protagonist Therapeutics (PTGX) Net Shares Issued and Repurchased (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Protagonist Therapeutics 9.61 Bn 9.61 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.11 Mn
Dec 31, 2024 2.07 Mn
Dec 31, 2023 2.52 Mn
Mar 31, 2023 2.20 Mn
Mar 31, 2022 1.12 Mn
Sep 30, 2016 7,752.00
Jun 30, 2016 17,894.00
Dec 31, 2015 408,623.00